Skip to content
ppharmaranks
Menu
Class IIOngoing

Phytonadione Injectable Emulsion recall

FDA recall D-0197-2026 · initiated Oct 31, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Dec 10, 2025How we research

Cipla Limited recalled Phytonadione Injectable Emulsion in Oct 2025 — an FDA Class II recall (D-0197-2026) because Failed Stability Specifications: Observed OOS results: eg results for colour index.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Failed Stability Specifications: Observed OOS results: eg results for colour index

Wrong strength, or it did not keep

The product did not contain what the label promised, or stopped meeting specification before its expiry date. Under-strength medicine can mean an untreated condition.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Batch # PH0072404A, PH0082404A, Exp. Date December 31, 2025

Quantity recalled: 4,438 10x1mL cartons

Details

Product
Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd. India At M/s Immacule Lifesciences PVT. Ltd. India. Mfd. for: Cipla USA, Inc. Warren, NJ 07059. Vial NDC# 69097-708-31; Carton NDC 69097-708-96
Recalling company
Cipla Limited
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Oct 31, 2025
FDA report date
Dec 10, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Phytonadione Injectable Emulsion recalled?
Cipla Limited recalled Phytonadione Injectable Emulsion in Oct 2025 — an FDA Class II recall (D-0197-2026) because Failed Stability Specifications: Observed OOS results: eg results for colour index. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Phytonadione Injectable Emulsion recalled?
Per the FDA enforcement record, the reason for recall D-0197-2026 was: Failed Stability Specifications: Observed OOS results: eg results for colour index
Is a recalled Phytonadione Injectable Emulsion dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Phytonadione Injectable Emulsion are affected?
Distributed: Nationwide in the USA. The recall covers these lots — Batch # PH0072404A, PH0082404A, Exp. Date December 31, 2025. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0197-2026.

Source: openFDA Drug Enforcement record D-0197-2026

← All drug recalls